NextPlat Corp (NXPL) Latest Filing Signal

Latest Filing: 10-K  |  Filed Mar 31, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for NextPlat Corp?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, NextPlat Corp's filing signal continuing negative.
earningsVibe SuperAnalyst™ Verdict: CONTINUING NEGATIVE

Signal Performance — Stock Price Since Filing

30-Day Change
Pending
from filing date
60-Day Change
Pending
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Continuing Negative
GEMINI
Continuing Negative
CLAUDE
Continuing Negative
CHATGPT
Continuing Negative

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does NextPlat Corp actually do?
Answer:
NextPlat Corp operates as a global e-commerce and healthcare services company, structured into two reportable segments: e-Commerce Operations and Healthcare Operations. The e-Commerce segment focuses on distributing satellite-enabled communication products and services, including phones, tracking devices, and connectivity plans, to over 165 countries through proprietary websites and third-party marketplaces like Amazon. The Healthcare segment, primarily through Progressive Care LLC, offers pharmacy services, including prescription fulfillment, medication therapy management, and 340B program participation, alongside data analytics and technology solutions via ClearMetrX. The company's strategy centers on expanding recurring revenue streams, enhancing global e-commerce distribution, and leveraging healthcare data to improve patient outcomes.
Question:
What are NextPlat Corp's revenue drivers?
Answer:
Revenue is driven by product sales (satellite phones, tracking devices, terminals) and recurring service revenue (airtime subscriptions, connectivity services) in the e-commerce segment, and by prescription pharmaceuticals, compounded medications, and contracted pharmacy services in the healthcare segment.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required